Skip to content
10-Q

Quarterly Report

Edwards Lifesciences Corp EW

0001099800-25-000062

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 580.3M sh
Shares Diluted Q3 2025 · Sep 30, 2025 585.7M sh
Shares Diluted Q3 2025 · Sep 30, 2025 587.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 598.1M sh
Shares Diluted Q3 2025 · Sep 30, 2024 602.2M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $852.8M
Stock Repurchased Q3 2025 · Sep 30, 2024 $1.06B
Capex Q3 2025 · Sep 30, 2025 $162.8M
Capex Q3 2025 · Sep 30, 2024 $202.6M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $1.14B
Operating Cash Flow Q3 2025 · Sep 30, 2024 $669.8M
Long Term Debt Q3 2025 · Sep 30, 2025 $598.2M
Long Term Debt Q3 2025 · Dec 31, 2024 $597.7M
Short Term Investments Q3 2025 · Sep 30, 2025 $1.16B
Short Term Investments Q3 2025 · Dec 31, 2024 $930.7M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $2.69B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.05B
Stockholders Equity Q3 2025 · Sep 30, 2025 $10.21B
Stockholders Equity Q3 2025 · Dec 31, 2024 $10B
Current Liabilities Q3 2025 · Sep 30, 2025 $1.59B
Current Liabilities Q3 2025 · Dec 31, 2024 $1.51B
Total Liabilities Q3 2025 · Sep 30, 2025 $3.07B
Total Liabilities Q3 2025 · Dec 31, 2024 $2.99B
Current Assets Q3 2025 · Sep 30, 2025 $6.36B
Current Assets Q3 2025 · Dec 31, 2024 $6.29B
Total Assets Q3 2025 · Sep 30, 2025 $13.27B
Total Assets Q3 2025 · Dec 31, 2024 $13.06B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.50
Eps Diluted Q3 2025 · Sep 30, 2025 $1.67
Eps Diluted Q3 2025 · Sep 30, 2024 $5.13
Eps Diluted Q3 2025 · Sep 30, 2024 $6.29
Eps Basic Q3 2025 · Sep 30, 2025 $0.50
Eps Basic Q3 2025 · Sep 30, 2025 $1.68
Eps Basic Q3 2025 · Sep 30, 2024 $5.14
Eps Basic Q3 2025 · Sep 30, 2024 $6.31
Sga Expense Q3 2025 · Sep 30, 2025 $514.6M
Sga Expense Q3 2025 · Sep 30, 2025 $1.48B
Sga Expense Q3 2025 · Sep 30, 2024 $421.4M
Sga Expense Q3 2025 · Sep 30, 2024 $1.3B
Rd Expense Q3 2025 · Sep 30, 2025 $280.7M
Rd Expense Q3 2025 · Sep 30, 2025 $811.5M
Rd Expense Q3 2025 · Sep 30, 2024 $253.4M
Rd Expense Q3 2025 · Sep 30, 2024 $781.9M
Net Income Q3 2025 · Sep 30, 2025 $291.1M
Net Income Q3 2025 · Sep 30, 2025 $982.3M
Net Income Q3 2025 · Sep 30, 2024 $3.07B
Net Income Q3 2025 · Sep 30, 2024 $3.79B
Operating Income Q3 2025 · Sep 30, 2025 $307.1M
Operating Income Q3 2025 · Sep 30, 2025 $1.11B
Operating Income Q3 2025 · Sep 30, 2024 $350.6M
Operating Income Q3 2025 · Sep 30, 2024 $1.07B
Gross Profit Q3 2025 · Sep 30, 2025 $1.21B
Gross Profit Q3 2025 · Sep 30, 2025 $3.51B
Gross Profit Q3 2025 · Sep 30, 2024 $1.09B
Gross Profit Q3 2025 · Sep 30, 2024 $3.23B
Cost Of Revenue Q3 2025 · Sep 30, 2025 $345.2M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $991.2M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $262.9M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $825.3M
Revenue Q3 2025 · Sep 30, 2025 $1.55B
Revenue Q3 2025 · Sep 30, 2025 $4.5B
Revenue Q3 2025 · Sep 30, 2024 $1.35B
Revenue Q3 2025 · Sep 30, 2024 $4.05B